Pharmaceutical Manufacturing News and Research

RSS

Study finds fiftyfold increase in U.S. methamphetamine mortality rate between 1999 and 2021

The U.S. methamphetamine mortality rate increased fiftyfold between 1999 and 2021, with most of the added deaths also involving heroin or fentanyl, researchers report in the American Journal of Public Health.

20 Feb 2023

SP Industries rebrands as ATS Life Sciences Scientific Products

SP Industries, Inc., (“Scientific Products”) a leading global provider of fill-finish drug manufacturing solutions, lyophilizers, and laboratory equipment and supplies, is now going to market as ATS Life Sciences Scientific Products.

From ATS Life Sciences Scientific Products 14 Feb 2023

Human health at risk from antibiotic residues in wastewater

In a recent study published in The Lancet Planetary Health, researchers explored antibiotic levels and antibiotic resistance among aquatic settings.

10 Jan 2023

Antibiotic concentrations in aquatic environments may pose a threat to human health

Antibiotic residues in wastewater and wastewater treatment plants in the regions around China and India risk contributing to antibiotic resistance, and the drinking water may pose a threat to human health, according to a comprehensive analysis from Karolinska Institutet published in The Lancet Planetary Health.

4 Jan 2023

Scientists suggest vibrational spectroscopy and nuclear magnetic resonance to evaluate drug concentrations

Scientists at Baltic Federal University have suggested evaluating concentration and chemical composition of drugs by means of vibrational spectroscopy and nuclear magnetic resonance instead of conventional complex approaches.

20 Dec 2022

Indonesian government orders temporary ban of cough syrups after Gambian tragedy

Following a WHO warning about possible toxic ingredients in four cough syrups of Indian origin, the Indonesian government has ordered a temporary ban on all liquid medicines in the country over reported spike in children's deaths linked to medical syrups.

28 Oct 2022

New biosensor system derived from E. coli bacteria could accelerate drug development

For more affordable, sustainable drug options than we have today, the medication we take to treat high blood pressure, pain or memory loss may one day come from engineered bacteria, cultured in a vat like yogurt.

7 Jul 2022

New technology enables single-cell sorting based on functional outputs

For nearly 40 years, drugmakers have used genetically engineered cells as tiny drug factories. Such cells can be programmed to secrete compounds that yield drugs used to treat cancer and autoimmune conditions such as arthritis.

20 Apr 2022

Current and future perspectives of mRNA technology

New research reports on the current and future perspectives on messenger ribonucleic acid technology, the platform on which the first successful COVID-19 vaccine was based.

8 Mar 2022

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology - Enabling solutions for biopharmaceutical development and production -

Yokogawa announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services.

From Yokogawa Electric Corporation 3 Nov 2021

Developing New Technology for the Encapsulation of mRNA-Based Vaccines in Lipid Nanoparticles (LNPs)

NewsMed speaks to KNAUER about the company’s background, its range of specialisms and its pioneering work to facilitate the largescale production of LNPs while meeting the stringent regulations and exacting demands of the biopharmaceutical industry.

From KNAUER Wissenschaftliche Geräte GmbH 14 Oct 2021

German chancellor delighted after company visit to KNAUER, calling the company a pearl

German Chancellor Dr. Angela Merkel visited Berlin-based manufacturer of high-tech laboratory instruments KNAUER Wissenschaftliche Geräte GmbH on Friday, Sept. 10, 2021.

From KNAUER Wissenschaftliche Geräte GmbH 16 Sep 2021

PAHO to launch new platform to boost regional COVID-19 vaccine manufacturing efforts

Pan American Health Organization Director Carissa F. Etienne said the severe shortage of COVID-19 vaccines in Latin America and the Caribbean is a "wake-up call" for increased regional production of vaccines and announced the start of a new platform to reach that goal.

1 Sep 2021

Rice bioengineer receives Trailblazer Award to develop technology for reprogramming immune cells

Viruses come in many forms, and Rice University bioengineer Isaac Hilton has long been fascinated by the kind that take control of cells without rewriting their genetic code.

23 Aug 2021

DNA recovered from illicit drug capsules could be used to track down criminal syndicates

Forensic scientists have for the first time shown that DNA can be recovered from the surface of capsules after just 15 seconds of contact by drug manufacturers & dealers – making it possible for law enforcement agencies to track down criminal syndicates around the world.

6 Aug 2021

Analysis: Necessary or not, covid booster shots are probably on the horizon

The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot to be effectively protected against new variants of covid-19 and that the company would apply for Food and Drug Administration emergency use authorization for the shot.

21 Jul 2021

WHO, COVAX partners work with South African consortium to build COVID-19 vaccine technology transfer hub

The World Health Organization and its COVAX partners are working with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a network of universities and the Africa Centres for Disease Control and Prevention (CDC) to establish its first COVID mRNA vaccine technology transfer hub.

24 Jun 2021

Scientists use new technology to optimize drug development for brain diseases

Dr. Hayder Amin and Dr. Caghan Kizil from the DZNE's Dresden site aim to speed up developing drugs against brain diseases through cutting-edge technology.

24 Jun 2021

New framework establishes safe thresholds for antimicrobials

Researchers have made progress towards a G7 commitment to establish safe standards for the release of antimicrobials into the environment, by developing a new framework that establishes safe thresholds.

11 Jun 2021

Chemical engineers devise a simpler process to incorporate hydrophobic drugs into tablets

About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into tablets because they need to be broken down into very small crystals in order to be absorbed by the human body.

8 Jun 2021